Blog
RSS FeedPosted by Michael Wonder on 25 Jun 2020
NICE draft guidance does not recommend siponimod for treating secondary progressive multiple sclerosis
25 June 2020 - NICE has today issued draft guidance for public consultation which does not recommend siponimod (Mayzent, Novartis) for ...
Posted by Michael Wonder on 25 Jun 2020
Cancer patients to benefit from new histology independent treatment
25 June 2020 - Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug ...
Posted by Michael Wonder on 24 Jun 2020
Looking back, UK patients unhappy with adalimumab biosimilar switch
24 June 2020 - The UK results show how challenging switching to a biosimilar can be, according to patient groups. ...
Posted by Michael Wonder on 24 Jun 2020
NICE publishes final guidance for Sobi's avatrombopag maleate
24 June 2020 - Avatrombopag maleate is used to treat patients with thrombocytopenia. ...
Posted by Michael Wonder on 24 Jun 2020
NICE begins phased restart of non-COVID-19 guidance
24 June 2020 - NICE has begun a phased restart of publishing non-COVID-19 guidance as the NHS and wider health ...
Posted by Michael Wonder on 23 Jun 2020
MHRA extends access to Santhera's DMD drug via the EAMS
23 June 2020 - The UK’s Medicines and Healthcare products Regulatory Agency has renewed for a further year the Early ...
Posted by Michael Wonder on 18 Jun 2020
Harnessing the power of health taxes
18 June 2020 - Health taxes are a cost effective opportunity for progress in public health. ...
Posted by Michael Wonder on 18 Jun 2020
Government authorises use of dexamethasone for COVID-19
18 June 2020 - The UK has authorised immediate use of dexamethasone on the NHS, widening access to the first ...
Posted by Michael Wonder on 18 Jun 2020
UK launches world's first ‘subscription-style’ payment model for antibiotics
18 June 2020 - A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies ...
Posted by Michael Wonder on 17 Jun 2020
Disagreement on cancer drug decisions in Europe
15 June 2020 - Despite the efforts of the European Union to promote voluntary cooperation among Health Technology Assessment agencies, different ...
Posted by Michael Wonder on 17 Jun 2020
Final NICE green light for Janssen's Stelara in ulcerative colitis
17 June 2020 - NICE has now issued a final green light for NHS use of Janssen's Stelara (ustekinumab) to ...
Posted by Michael Wonder on 15 Jun 2020
The unprecedented challenge of pricing a coronavirus vaccine
12 June 2020 - The optimal pricing strategy for a new vaccine involves setting a fair and sustainable price that ...
Posted by Michael Wonder on 15 Jun 2020
NICE backs Rozlytrek for subset of NSCLC patients
15 June 2020 - NICE has published final draft guidance backing NHS use of Roche's Rozlytrek (entrectinib) as a treatment ...
Posted by Michael Wonder on 12 Jun 2020
NICE rejects Sanofi's Cablivi in draft guidelines
12 June 2020 - NICE has drawn up draft guidelines rejecting Sanofi's Cablivi (caplacizumab) for use alongside plasma exchange and immunosuppression ...
Posted by Michael Wonder on 11 Jun 2020
Tafamidis for treating transthyretin amyloid cardiomyopathy
11 June 2020 - The Department of Health and Social Care has asked the NICE to produce guidance on using tafamidis ...